Dual-Antigen Targeting Yields 79 Percent Response in Drug-Resistant True extramedullary myeloma, suggests study Aashi verma10 April 2026 8:45 PM ISTA remarkable clinical response was achieved in 79% of patients battling drug-resistant, true extramedullary myeloma (EMM) through an innovative...
GLP-1RAs Expanding Clinical Scope Beyond Glycemic Control: Review Suggests Aashi verma10 April 2026 8:45 PM ISTGlucagon-like peptide-1 receptor agonists (GLP-1RAs) have remarkably transitioned from specialized diabetes treatments to versatile therapeutic agents...
Spironolactone may not reduce CV mortality and hospitalizations in patients with HFpEF or HFmrEF: SPIRIT-HF Trial Aashi verma8 April 2026 9:30 AM ISTSpironolactone showed no significant benefit in reducing the composite of cardiovascular mortality and heart failure hospitalizations, recording 12.7...
GH001 Shows Promise as Rapid-Acting Therapy for Treatment-Resistant Depression: JAMA Aashi verma27 March 2026 8:30 PM ISTAn individualized dosing regimen of GH001, a synthetic inhaled form of mebufotenin, significantly improved depressive symptoms compared to placebo and...
Finerenone Achieves 25 Percent Greater Albuminuria Reduction in Type 1 Diabetes and CKD: FINE-ONE Study Finds Aashi verma25 March 2026 8:00 AM ISTFinerenone achieves a 25% greater reduction in albuminuria compared to placebo in adults with type 1 diabetes and chronic kidney disease, a recent...
TRIUMPH Program Showcases Retatrutide's Potency of 24 Percent Weight Loss: Study Finds Aashi verma24 March 2026 9:00 PM ISTThe TRIUMPH program's innovative approach suggests that retatrutide could offer a clinical breakthrough in managing obesity-related morbidity by...
Coronary Injury Prevention: IHJ, 2025 Study Introduces Floating Aortic Wire Technique Aashi verma15 March 2026 10:00 PM ISTA recent clinical study has demonstrated that a novel "floating aortic wire" technique successfully prevents deep guide engagement in 92% of cases...
Lactation-Safe Postpartum Hypertension Management: Curr. Probl. Cardiol., 2025 Review Highlights Aashi verma11 March 2026 8:00 PM ISTPostpartum hypertension is effectively managed using lactation-safe first-line agents like nifedipine and enalapril, which, when combined with...
Interleukin-36 as a Novel Therapeutic Target for Atherosclerosis Pathogenesis: Curr. Probl. Cardiol., 2025 Review Highlights Aashi verma6 March 2026 9:00 PM ISTA recent review identifies interleukin-36 (IL-36) as a transformative driver of vascular inflammation, revealing that serum concentrations in patients...
Presence to Precision: Moving beyond Omnichannel - Gurpinder Singh Gurpinder Singh6 March 2026 3:17 PM ISTThe pharma industry's legacy is based on constant innovation, particularly in the R&D space. Undoubtedly, science has made strides in treating...
Women Face Lower Odds of Receiving High-Potency P2Y12 Inhibitors After Heart Attack: CRM, July 2025 Analysis Finds Aashi verma3 March 2026 8:45 PM ISTA recent analysis found that among patients with acute myocardial infarction (AMI) undergoing percutaneous coronary intervention (PCI), women are less...
Vitamin D Status a Relevant Prognostic Factor in FET Cycles: Recent Cureus Systematic Review Finds Aashi verma1 March 2026 8:45 PM ISTA recent systematic review and meta-analysis revealed that maternal vitamin D deficiency or insufficiency (<20-30 ng/mL) is linked to poorer...
